This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Preclinical Evaluation of 18F-LMI1195 for In Vivo Imaging of Pheochromocytoma in the MENX Tumor Model
- Modern Nuclear Imaging for Paragangliomas: Beyond SPECT
- 18F-FDOPA PET and PET/CT Accurately Localize Pheochromocytomas
- Comparison of 6-18F-Fluorodopamine PET with 123I-Metaiodobenzylguanidine and 111In-Pentetreotide Scintigraphy in Localization of Nonmetastatic and Metastatic Pheochromocytoma
- Pheochromocytoma: Current Approaches and Future Directions
- Pheochromocytoma: an update on genetics and management
- Presence of Specific 11C-meta-Hydroxyephedrine Retention in Heart, Lung, Pancreas, and Brown Adipose Tissue
- The diagnosis and management of malignant phaeochromocytoma and paraganglioma
- Whole-Body PET/CT with 11C-Meta-Hydroxyephedrine in Tumors of the Sympathetic Nervous System: Feasibility Study and Comparison with 123I-MIBG SPECT/CT
- The Human Norepinephrine Transporter in Combination with 11C-m-Hydroxyephedrine as a Reporter Gene/Reporter Probe for PET of Gene Therapy
- Diagnosis and Localization of Pheochromocytoma
- The Diagnostic Role of Radionuclide Imaging in Evaluation of Patients with Nonhypersecreting Adrenal Masses
- Quantitative PET Studies in Pretreated Melanoma Patients: A Comparison of 6-[18F]Fluoro-L-Dopa with 18F-FDG and 15O-Water Using Compartment and Noncompartment Analysis